Skip to content

Author

Angelo Fassio

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.

OBJECTIVE The objective of this study was to evaluate the real-world effectiveness and safety of secukinumab in giant cell arteritis (GCA) patients. METHODS This multicentre retrospective study included patients with GCA who received secukinumab at 14 Italian centres with at least 6 months of follow-up. Outcomes incl...

Luca Iorio, Federica Davanzo, C. Ricordi et al. · 0 citations
Open access Aug 2026

Long-term effects of denosumab: a 10-year single-center retrospective study

Osteoporosis weakens bones and increases the risk of fractures. Denosumab is a medication that reduces bone loss and increases bone mineral density (BMD). In this real-world study, we followed patients who received denosumab every 6 months for 10 years. We found that bone density continued to improve throughout treatme...

F. Aldegheri, Matteo Appoloni, Nicolò Passoni et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.